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Sickle cell disease is an autosomal recessive hemoglobinopathy and is due to the replacement of valine for glutamic acid in position 6 of the beta globin chain of hemoglobin (Hb). This 
alteration leads to an unstable sickle-shaped red blood cell under 
hypoxic condition with a shortened life span of 10-20 days instead of 
the normal 120 days. Sickle cell disease refers not only to patients with 
sickle cell anemia (SCA) (HbSS, sickle cell Hb [HbS] >90%), but 
also to compound heterozygotes (HbS >50%) with a gene mutation 
other than the sickle cell mutation such as HbC, β thalassemia, HbD 
and HbO. In individual with sickle cell trait (SCT), the HbS level is 
<50%, thus having mild or no clinical manifestations [1].
The sickle cell gene in India was first described among tribal 
groups in South India but is now recognized to be widespread 
and prevalent in many parts of India, especially in central India, 
where the prevalence in different communities has ranged from 
9.4% to 22% [2-4]. Clinically, SCA in India is moderate to severe 
with high HbF level. It is milder than SCA in Africa and similar 
to in central Asia [5].
Since little recent published data are available on this disease 
from Southern Rajasthan, we undertook the present study. Sickle 
cell disease in this tribal area poses difficulty in diagnosis and 
management as the sign and symptoms overlap with other 
prevalent common diseases. Our emphasis was to sensitize health 
care providers about the same.
MATERIALS AND METHODS
During May 2014-December 2015, health checkup camps for 
tribal children were organized by tertiary care hospital in Sirohi 
and Udaipur district of Rajasthan. Only tribal (Garasia) children 
under the age of 15 years were included in the study, who 
attended the health camps on their own. Children with known 
case of other hemolytic diseases such as thalassemia, G6PD, 
etc. were excluded from the study. Sickle cell disease is endemic 
in tribal parts of India, assuming its prevalence 12%, minimal 
sample size for a random sample at 95% confidence level with 
absolute precision of 2%, was computed as 1014 (according to 
Daniel 1999 formula). Multistage sampling was used to cover all 
geographical areas of both districts.
Children were screened by sickling test (with freshly prepared 
sodium metabisulfite), and Hb estimation (by Sahli’s acid 
hematin method) was done on blood sample collected by finger 
prick. Sickling positive children were further evaluated by Hb 
electrophoresis (on cellulose acetate membrane) to confirm the 
diagnosis and to classify them as SCA (Hb SS) or SCT (Hb AS) [6]. 
Participants’ details were recorded including age, sex, relevant 
history, clinical examination findings, and laboratory parameters. 
Statistical analysis was done by simple proportions and Chi-
square test. The study was carried out after getting clearance from 
Institute Ethics Committee.
RESULTS
A total of 1090 children were screened. The prevalence of 
sickle cell disease among tribal (Garasia) children of Sirohi 
and Udaipur district was found to be 8.53% (93/1090) of which 
0.77% (9/1090) were homozygous (SCA, Hb SS), whereas 
7.7% (84/1090) were heterozygous (SCT, HbAS). Out of 1090 
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children, 687 (63.02%) were males, and 403 (36.97%) were 
females. 57 (8.29%) male children and 36(8.9%) female children 
were having sickle cell disease. The difference in sex wise 
prevalence was not found statistically significant (χ2=0.1317; 
df=1; p=0.7167).
A total of 29 (6.56%) children in the age group of 0-4 years, 
56 (10.03%) in the age group of 5-9 years, and 8 (8.88%) in the 
age group of 10-15 years were suffering from sickle cell disease. 
The difference in age wise prevalence of sickle cell disease was 
found to be not significant (χ2=3.8318; df=2, p=0.1472). Among 
SCA (Hb SS) cases, 4 were among 0-4 years age group, 3 from 
5 to 9 years age group, and 2 were from 10 to 15 years age group. 
Among SCT (Hb AS) cases, 25 were from 0 to 4 years age group, 
54 from 5 to 9 years age group, and 6 were from 10 to 15 years 
age group (Table 1).
Among sickle cell anima (Hb SS) cases, main complaints 
were pain in 9 (100%), weakness/fatigability in 7 (77%), and 
fever in 6 (66.6%) patients. Pallor was the most common clinical 
sign observed in all 9 (100%) patients followed by splenomegaly 
in 7 (77%) patients. Hepatomegaly was observed in 5 (55.5%) 
patients. Jaundice was observed in 3 (33%) patients and gall 
stones in 1 patient. Two patients presented with pneumonia. 
Severe anemia (Hb <7 g%) was observed in 5 (55%) patients. 
Vasoocclusive crisis was observed in 4 patients (44.4%) (Table 2).
Among children with SCT main symptoms were weakness/
fatigability 63 (75%), fever 34 (40.47%), and abdominal pain 
28 (33.3%). Pallor was the most common sign observed in 
74 (88%) patients followed by splenomegaly in 17 (20.2%) 
patients. Severe anemia (Hb <7 g%) was observed in 6 (7.14%) 
patients. In addition to anemia and splenomegaly, ARI (20.8%), 
severe acute malnutrition (16.7%) and vitamin deficiencies (6%) 
were encountered. Malaria parasite was not detected in any of 
them (Table 2).
DISCUSSION
The childhood diseases in the tribal area pose difficulty 
for diagnosis and management as the sign and symptoms of 
sickle cell disease overlap with other common prevalent 
diseases. Only high suspicion and screening can guide the 
health-care providers for better management of cases and 
prevent morbidities and mortalities. This study highlights the 
epidemiological and clinical picture of Sickle cell disorder in 
the tribal children.
The prevalence of Sickle cell disease in this study (8.53%) is 
similar to that reported from Orissa, Madhya Pradesh, Chhattisgarh, 
and Maharashtra, i.e., between 3.2% and 22.5% [2,3,5,7-9]. There 
was no significant difference in sex wise prevalence of sickle cell 
disease, and it is observed by other studies also [7-9]. The ratio of 
homozygous and heterozygous disease is very less as compared 
to observed by Kamble and Chatruvedi, who showed SCA in 
61.6% whereas, SCT in 38.4% [10]. A similar finding was also 
observed in a study done by Patra et al., i.e. SCA in 59.1% and 
SCT in 40.9% [11].
In this study, among SCA (HbSS), 4 were diagnosed before 
3 years of age, and total 7 (77.7%) were diagnosed before 6 years 
of age. About 66.6% cases with SCT presented before the age 
of 5 years. An earlier study from Orissa found 50% patients to 
be symptomatic before 5 years of age, whereas in a study from 
Jamaica, 90% were symptomatic by the age of 5 years [8,12]. 
According to Kar, 75% of the children had their, first manifestation 
within 10 years of age [8].
Pain, fatigability, and fever were the most common symptoms. 
Anemia was the most common association. The majority of the 
case had mild to moderate anemia. Besides sickle cell disease 
nutritional deficiency and infections may also contribute to 
anemia. Mean Hb value was found to be 7.8 g% which is similar 
to other studies [5,13]. Splenomegaly was found in 25.8% of 
children and was more in SCA children (77%). Splenomegaly 
was reported by many workers (24-70%) [7-9,11].
Neonatal screening for sickle cell disease in this high-
risk population (tribal scheduled caste) might be very helpful. 
Once the cases are identified, counselors should explain to the 
parents about general supportive and preventive measures such 
as maintaining hydration, avoiding stress and adverse climatic 
conditions, early treatment of infections, and immunization.
We acknowledge that a community-based study is ideal to 
know the true prevalence of the disease, but because of the ethical/
social issues involved, it is difficult to conduct a community-
based study involving invasive procedure (blood collection), 
especially in pediatric age group. However, this hospital-based 
study is important for sensitization and can serve as a baseline for 
generating more data.
Table 2: Clinical manifestations of sickle cell disease
Parameters Symptom/signs SCA (%) SCT (%)
Presenting symptoms Bone pain 9 (100) 5 (5.9)
Abdominal pain 3 (33.3) 28 (33.3)
Generalized weakness 7 (77.7) 63 (75)
Fever 6 (66.6) 34 (40.47)
Presenting signs Pallor 9 (100) 74 (88)
Splenomegaly 7 (77.7) 17 (20.8)
Hepatomegaly 5 (55.5) 6 (7.1)
Jaundice 3 (33.3) 0
Other manifestations Gall stones 2 (22.2) 0
Pneumonia 2 (22) 3 (3.57)
Vasoocclusive crisis 4 (44.4) 0
SCT: Sickle cell trait, SCA: Sickle cell anemia
Table 1: Age and sex wise distribution of sickle cell disease
Age group
(years)
SS type (n=9) AS type (n=84) Total
Male Female Total Male Female Total
0-4 3 1 4 16 9 25 29/442
5-9 1 2 3 31 22 53 56/558
10-15 1 1 2 4 2 6 08/90
Total 5 4 9 52 32 84 93/1090
Age wise prevalence (χ2=3.8318; df=2, p<0.05), Sex wise prevalence (χ2=0.1317; df=1; 
p<0.05). SS: Homozygous Sickle cell disease, AS: Heterozygous Sickle cell disease
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CONCLUSION
Sickle cell disease is prevalent in this area. Recurrent attacks of 
musculoskeletal pain, anemia, frequent respiratory infections, 
jaundice, and splenomegaly, are the features which should arouse 
the suspicion of sickle cell disease. Early detection of sickle cell 
disease is useful for improving the quality of life in these tribal 
children.
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